Seven Bridge Financial Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Seven Bridge Financial Group, LLC
- $443 Million
- Q1 2024
A detailed history of Seven Bridge Financial Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 741 shares of REGN stock, worth $774,093. This represents 0.16% of its overall portfolio holdings.
Number of Shares
741
Previous 896
17.3%
Holding current value
$774,093
Previous $786,000
9.29%
% of portfolio
0.16%
Previous 0.19%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.33 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.95 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.07 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.06 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.86 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $112B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...